Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0OWCGK
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
hIMB1636-MMAE
|
|||||
| Synonyms |
hIMB1636-MMAE
Click to Show/Hide
|
|||||
| Organization |
Chinese Academy of Medical Sciences and Peking Union Medical College.
|
|||||
| Drug Status |
Investigative
|
|||||
| Structure |
|
|||||
| Antibody Name |
hIMB1636
|
Antibody Info | ||||
| Antigen Name |
Tumor-associated calcium signal transducer 2 (TACSTD2)
|
Antigen Info | ||||
| Payload Name |
Monomethyl auristatin E
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
Mc-Val-Cit-PABC
|
Linker Info | ||||
| Conjugate Type |
Site-specific conjugation via lipoate ligase A (LplA)
|
|||||
| Combination Type |
Vedotin
|
|||||
General Information of The Activity Data Related to This ADC
Revealed Based on the Cell Line Data
Full List of Activity Data of This Antibody-drug Conjugate
Revealed Based on the Cell Line Data
| Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) | 0.24۪.17 nM | High TROP2 expression (TROP2++) | ||
| Method Description |
The cytotoxicity of hIMB1636-MMAE and free MMAE was evaluated by the Cell Counting Kit-8 (CCK-8) assay (Dojindo, Kyushu, Japan). Cells were plated at 2 × 103 to 8 × 103 cells/well in 100 uL culture medium into 96-well plates. Following an overnight incubation at 37 °C, the cells were cultured continuously for 48 h in 100 uL of medium containing various concentrations of drugs (100, 10, 1, 0.1, 0.01, and 0.001 nM). Then, the medium was replaced with 100 uL of fresh medium containing 10% CCK-8 reagent and incubated for 1 h. The absorbance was measured at 450 nm by a SpectraMax i3x Multi-Mode microplate reader (Molecular Devices, LLC, USA). The half-maximal inhibitory concentration (IC50) of the samples was calculated by Prism GraphPad 6.0 (GraphPad Software, San Diego, CA). The data are presented as the mean ± SD for three independent experiments.
Click to Show/Hide
|
||||
| In Vitro Model | Skin squamous cell carcinoma | A431 cells | CVCL_0037 | ||
| Experiment 2 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) | 0.43۪.48 nM | Moderate TROP2 expression (TROP2++) | ||
| Method Description |
The cytotoxicity of hIMB1636-MMAE and free MMAE was evaluated by the Cell Counting Kit-8 (CCK-8) assay (Dojindo, Kyushu, Japan). Cells were plated at 2 × 103 to 8 × 103 cells/well in 100 uL culture medium into 96-well plates. Following an overnight incubation at 37 °C, the cells were cultured continuously for 48 h in 100 uL of medium containing various concentrations of drugs (100, 10, 1, 0.1, 0.01, and 0.001 nM). Then, the medium was replaced with 100 uL of fresh medium containing 10% CCK-8 reagent and incubated for 1 h. The absorbance was measured at 450 nm by a SpectraMax i3x Multi-Mode microplate reader (Molecular Devices, LLC, USA). The half-maximal inhibitory concentration (IC50) of the samples was calculated by Prism GraphPad 6.0 (GraphPad Software, San Diego, CA). The data are presented as the mean ± SD for three independent experiments.
Click to Show/Hide
|
||||
| In Vitro Model | Lung adenocarcinoma | HCC827 cells | CVCL_2063 | ||
| Experiment 3 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) | 0.68۪.31 nM | Moderate TROP2 expression (TROP2++) | ||
| Method Description |
The cytotoxicity of hIMB1636-MMAE and free MMAE was evaluated by the Cell Counting Kit-8 (CCK-8) assay (Dojindo, Kyushu, Japan). Cells were plated at 2 × 103 to 8 × 103 cells/well in 100 uL culture medium into 96-well plates. Following an overnight incubation at 37 °C, the cells were cultured continuously for 48 h in 100 uL of medium containing various concentrations of drugs (100, 10, 1, 0.1, 0.01, and 0.001 nM). Then, the medium was replaced with 100 uL of fresh medium containing 10% CCK-8 reagent and incubated for 1 h. The absorbance was measured at 450 nm by a SpectraMax i3x Multi-Mode microplate reader (Molecular Devices, LLC, USA). The half-maximal inhibitory concentration (IC50) of the samples was calculated by Prism GraphPad 6.0 (GraphPad Software, San Diego, CA). The data are presented as the mean ± SD for three independent experiments.
Click to Show/Hide
|
||||
| In Vitro Model | Esophageal squamous cell carcinoma, Squamous cell carcinoma of the esophagus | KYSE150 cells | CVCL_1348 | ||
| Experiment 4 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) | 0.73۪.21 nM | High TROP2 expression (TROP2++) | ||
| Method Description |
The cytotoxicity of hIMB1636-MMAE and free MMAE was evaluated by the Cell Counting Kit-8 (CCK-8) assay (Dojindo, Kyushu, Japan). Cells were plated at 2 × 103 to 8 × 103 cells/well in 100 uL culture medium into 96-well plates. Following an overnight incubation at 37 °C, the cells were cultured continuously for 48 h in 100 uL of medium containing various concentrations of drugs (100, 10, 1, 0.1, 0.01, and 0.001 nM). Then, the medium was replaced with 100 uL of fresh medium containing 10% CCK-8 reagent and incubated for 1 h. The absorbance was measured at 450 nm by a SpectraMax i3x Multi-Mode microplate reader (Molecular Devices, LLC, USA). The half-maximal inhibitory concentration (IC50) of the samples was calculated by Prism GraphPad 6.0 (GraphPad Software, San Diego, CA). The data are presented as the mean ± SD for three independent experiments.
Click to Show/Hide
|
||||
| In Vitro Model | Pancreatic ductal adenocarcinoma | BxPC-3 cells | CVCL_0186 | ||
| Experiment 5 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) | 1.22۪.48 nM | High TROP2 expression (TROP2++) | ||
| Method Description |
The cytotoxicity of hIMB1636-MMAE and free MMAE was evaluated by the Cell Counting Kit-8 (CCK-8) assay (Dojindo, Kyushu, Japan). Cells were plated at 2 × 103 to 8 × 103 cells/well in 100 uL culture medium into 96-well plates. Following an overnight incubation at 37 °C, the cells were cultured continuously for 48 h in 100 uL of medium containing various concentrations of drugs (100, 10, 1, 0.1, 0.01, and 0.001 nM). Then, the medium was replaced with 100 uL of fresh medium containing 10% CCK-8 reagent and incubated for 1 h. The absorbance was measured at 450 nm by a SpectraMax i3x Multi-Mode microplate reader (Molecular Devices, LLC, USA). The half-maximal inhibitory concentration (IC50) of the samples was calculated by Prism GraphPad 6.0 (GraphPad Software, San Diego, CA). The data are presented as the mean ± SD for three independent experiments.
Click to Show/Hide
|
||||
| In Vitro Model | Pancreatic ductal adenocarcinoma | T3M4 cells | CVCL_4056 | ||
| Experiment 6 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) | 1.55۪.17 nM | Moderate TROP2 expression (TROP2++) | ||
| Method Description |
The cytotoxicity of hIMB1636-MMAE and free MMAE was evaluated by the Cell Counting Kit-8 (CCK-8) assay (Dojindo, Kyushu, Japan). Cells were plated at 2 × 103 to 8 × 103 cells/well in 100 uL culture medium into 96-well plates. Following an overnight incubation at 37 °C, the cells were cultured continuously for 48 h in 100 uL of medium containing various concentrations of drugs (100, 10, 1, 0.1, 0.01, and 0.001 nM). Then, the medium was replaced with 100 uL of fresh medium containing 10% CCK-8 reagent and incubated for 1 h. The absorbance was measured at 450 nm by a SpectraMax i3x Multi-Mode microplate reader (Molecular Devices, LLC, USA). The half-maximal inhibitory concentration (IC50) of the samples was calculated by Prism GraphPad 6.0 (GraphPad Software, San Diego, CA). The data are presented as the mean ± SD for three independent experiments.
Click to Show/Hide
|
||||
| In Vitro Model | Breast adenocarcinoma | MDA-MB-468 cells | CVCL_0419 | ||
| Experiment 7 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) | 2.81۪.06 nM | High TROP2 expression (TROP2++) | ||
| Method Description |
The cytotoxicity of hIMB1636-MMAE and free MMAE was evaluated by the Cell Counting Kit-8 (CCK-8) assay (Dojindo, Kyushu, Japan). Cells were plated at 2 × 103 to 8 × 103 cells/well in 100 uL culture medium into 96-well plates. Following an overnight incubation at 37 °C, the cells were cultured continuously for 48 h in 100 uL of medium containing various concentrations of drugs (100, 10, 1, 0.1, 0.01, and 0.001 nM). Then, the medium was replaced with 100 uL of fresh medium containing 10% CCK-8 reagent and incubated for 1 h. The absorbance was measured at 450 nm by a SpectraMax i3x Multi-Mode microplate reader (Molecular Devices, LLC, USA). The half-maximal inhibitory concentration (IC50) of the samples was calculated by Prism GraphPad 6.0 (GraphPad Software, San Diego, CA). The data are presented as the mean ± SD for three independent experiments.
Click to Show/Hide
|
||||
| In Vitro Model | Hypopharyngeal squamous cell carcinoma | FaDu cells | CVCL_1218 | ||
| Experiment 8 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) | 15.02۪.09 nM | Negative TROP2 expression (TROP2-) | ||
| Method Description |
The cytotoxicity of hIMB1636-MMAE and free MMAE was evaluated by the Cell Counting Kit-8 (CCK-8) assay (Dojindo, Kyushu, Japan). Cells were plated at 2 × 103 to 8 × 103 cells/well in 100 uL culture medium into 96-well plates. Following an overnight incubation at 37 °C, the cells were cultured continuously for 48 h in 100 uL of medium containing various concentrations of drugs (100, 10, 1, 0.1, 0.01, and 0.001 nM). Then, the medium was replaced with 100 uL of fresh medium containing 10% CCK-8 reagent and incubated for 1 h. The absorbance was measured at 450 nm by a SpectraMax i3x Multi-Mode microplate reader (Molecular Devices, LLC, USA). The half-maximal inhibitory concentration (IC50) of the samples was calculated by Prism GraphPad 6.0 (GraphPad Software, San Diego, CA). The data are presented as the mean ± SD for three independent experiments.
Click to Show/Hide
|
||||
| In Vitro Model | Esophageal squamous cell carcinoma, Squamous cell carcinoma of the esophagus | Eca109 cells | CVCL_6898 | ||
| Experiment 9 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) | 15.86۪.51 nM | Low TROP2 expression (TROP2+) | ||
| Method Description |
The cytotoxicity of hIMB1636-MMAE and free MMAE was evaluated by the Cell Counting Kit-8 (CCK-8) assay (Dojindo, Kyushu, Japan). Cells were plated at 2 × 103 to 8 × 103 cells/well in 100 uL culture medium into 96-well plates. Following an overnight incubation at 37 °C, the cells were cultured continuously for 48 h in 100 uL of medium containing various concentrations of drugs (100, 10, 1, 0.1, 0.01, and 0.001 nM). Then, the medium was replaced with 100 uL of fresh medium containing 10% CCK-8 reagent and incubated for 1 h. The absorbance was measured at 450 nm by a SpectraMax i3x Multi-Mode microplate reader (Molecular Devices, LLC, USA). The half-maximal inhibitory concentration (IC50) of the samples was calculated by Prism GraphPad 6.0 (GraphPad Software, San Diego, CA). The data are presented as the mean ± SD for three independent experiments.
Click to Show/Hide
|
||||
| In Vitro Model | Invasive breast carcinoma | MCF-7 cells | CVCL_0031 | ||
| Experiment 10 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) | > 100 nM | Negative TROP2 expression (TROP2-) | ||
| Method Description |
The cytotoxicity of hIMB1636-MMAE and free MMAE was evaluated by the Cell Counting Kit-8 (CCK-8) assay (Dojindo, Kyushu, Japan). Cells were plated at 2 × 103 to 8 × 103 cells/well in 100 uL culture medium into 96-well plates. Following an overnight incubation at 37 °C, the cells were cultured continuously for 48 h in 100 uL of medium containing various concentrations of drugs (100, 10, 1, 0.1, 0.01, and 0.001 nM). Then, the medium was replaced with 100 uL of fresh medium containing 10% CCK-8 reagent and incubated for 1 h. The absorbance was measured at 450 nm by a SpectraMax i3x Multi-Mode microplate reader (Molecular Devices, LLC, USA). The half-maximal inhibitory concentration (IC50) of the samples was calculated by Prism GraphPad 6.0 (GraphPad Software, San Diego, CA). The data are presented as the mean ± SD for three independent experiments.
Click to Show/Hide
|
||||
| In Vitro Model | Pancreatic ductal adenocarcinoma | AsPC-1 cells | CVCL_0152 | ||
| Experiment 11 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) | > 100 nM | Negative TROP2 expression (TROP2-) | ||
| Method Description |
The cytotoxicity of hIMB1636-MMAE and free MMAE was evaluated by the Cell Counting Kit-8 (CCK-8) assay (Dojindo, Kyushu, Japan). Cells were plated at 2 × 103 to 8 × 103 cells/well in 100 uL culture medium into 96-well plates. Following an overnight incubation at 37 °C, the cells were cultured continuously for 48 h in 100 uL of medium containing various concentrations of drugs (100, 10, 1, 0.1, 0.01, and 0.001 nM). Then, the medium was replaced with 100 uL of fresh medium containing 10% CCK-8 reagent and incubated for 1 h. The absorbance was measured at 450 nm by a SpectraMax i3x Multi-Mode microplate reader (Molecular Devices, LLC, USA). The half-maximal inhibitory concentration (IC50) of the samples was calculated by Prism GraphPad 6.0 (GraphPad Software, San Diego, CA). The data are presented as the mean ± SD for three independent experiments.
Click to Show/Hide
|
||||
| In Vitro Model | Breast adenocarcinoma | MDA-MB-231 cells | CVCL_0062 | ||
| Experiment 12 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) | > 100 nM | Negative TROP2 expression (TROP2-) | ||
| Method Description |
The cytotoxicity of hIMB1636-MMAE and free MMAE was evaluated by the Cell Counting Kit-8 (CCK-8) assay (Dojindo, Kyushu, Japan). Cells were plated at 2 × 103 to 8 × 103 cells/well in 100 uL culture medium into 96-well plates. Following an overnight incubation at 37 °C, the cells were cultured continuously for 48 h in 100 uL of medium containing various concentrations of drugs (100, 10, 1, 0.1, 0.01, and 0.001 nM). Then, the medium was replaced with 100 uL of fresh medium containing 10% CCK-8 reagent and incubated for 1 h. The absorbance was measured at 450 nm by a SpectraMax i3x Multi-Mode microplate reader (Molecular Devices, LLC, USA). The half-maximal inhibitory concentration (IC50) of the samples was calculated by Prism GraphPad 6.0 (GraphPad Software, San Diego, CA). The data are presented as the mean ± SD for three independent experiments.
Click to Show/Hide
|
||||
| In Vitro Model | Colon cancer | HT29 cells | CVCL_A8EZ | ||
| Experiment 13 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) | > 100 nM | Negative TROP2 expression (TROP2-) | ||
| Method Description |
The cytotoxicity of hIMB1636-MMAE and free MMAE was evaluated by the Cell Counting Kit-8 (CCK-8) assay (Dojindo, Kyushu, Japan). Cells were plated at 2 × 103 to 8 × 103 cells/well in 100 uL culture medium into 96-well plates. Following an overnight incubation at 37 °C, the cells were cultured continuously for 48 h in 100 uL of medium containing various concentrations of drugs (100, 10, 1, 0.1, 0.01, and 0.001 nM). Then, the medium was replaced with 100 uL of fresh medium containing 10% CCK-8 reagent and incubated for 1 h. The absorbance was measured at 450 nm by a SpectraMax i3x Multi-Mode microplate reader (Molecular Devices, LLC, USA). The half-maximal inhibitory concentration (IC50) of the samples was calculated by Prism GraphPad 6.0 (GraphPad Software, San Diego, CA). The data are presented as the mean ± SD for three independent experiments.
Click to Show/Hide
|
||||
| In Vitro Model | Colon carcinoma | HCT116 cells | CVCL_0291 | ||
| Experiment 14 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) | > 100 nM | Low TROP2 expression (TROP2+) | ||
| Method Description |
The cytotoxicity of hIMB1636-MMAE and free MMAE was evaluated by the Cell Counting Kit-8 (CCK-8) assay (Dojindo, Kyushu, Japan). Cells were plated at 2 × 103 to 8 × 103 cells/well in 100 uL culture medium into 96-well plates. Following an overnight incubation at 37 °C, the cells were cultured continuously for 48 h in 100 uL of medium containing various concentrations of drugs (100, 10, 1, 0.1, 0.01, and 0.001 nM). Then, the medium was replaced with 100 uL of fresh medium containing 10% CCK-8 reagent and incubated for 1 h. The absorbance was measured at 450 nm by a SpectraMax i3x Multi-Mode microplate reader (Molecular Devices, LLC, USA). The half-maximal inhibitory concentration (IC50) of the samples was calculated by Prism GraphPad 6.0 (GraphPad Software, San Diego, CA). The data are presented as the mean ± SD for three independent experiments.
Click to Show/Hide
|
||||
| In Vitro Model | Colon adenocarcinoma | SW480 cells | CVCL_0546 | ||
| Experiment 15 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) | > 100 nM | Negative TROP2 expression (TROP2-) | ||
| Method Description |
The cytotoxicity of hIMB1636-MMAE and free MMAE was evaluated by the Cell Counting Kit-8 (CCK-8) assay (Dojindo, Kyushu, Japan). Cells were plated at 2 × 103 to 8 × 103 cells/well in 100 uL culture medium into 96-well plates. Following an overnight incubation at 37 °C, the cells were cultured continuously for 48 h in 100 uL of medium containing various concentrations of drugs (100, 10, 1, 0.1, 0.01, and 0.001 nM). Then, the medium was replaced with 100 uL of fresh medium containing 10% CCK-8 reagent and incubated for 1 h. The absorbance was measured at 450 nm by a SpectraMax i3x Multi-Mode microplate reader (Molecular Devices, LLC, USA). The half-maximal inhibitory concentration (IC50) of the samples was calculated by Prism GraphPad 6.0 (GraphPad Software, San Diego, CA). The data are presented as the mean ± SD for three independent experiments.
Click to Show/Hide
|
||||
| In Vitro Model | Lung large cell carcinoma | H460 cells | CVCL_0459 | ||
| Experiment 16 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) | > 100 nM | Negative TROP2 expression (TROP2-) | ||
| Method Description |
The cytotoxicity of hIMB1636-MMAE and free MMAE was evaluated by the Cell Counting Kit-8 (CCK-8) assay (Dojindo, Kyushu, Japan). Cells were plated at 2 × 103 to 8 × 103 cells/well in 100 uL culture medium into 96-well plates. Following an overnight incubation at 37 °C, the cells were cultured continuously for 48 h in 100 uL of medium containing various concentrations of drugs (100, 10, 1, 0.1, 0.01, and 0.001 nM). Then, the medium was replaced with 100 uL of fresh medium containing 10% CCK-8 reagent and incubated for 1 h. The absorbance was measured at 450 nm by a SpectraMax i3x Multi-Mode microplate reader (Molecular Devices, LLC, USA). The half-maximal inhibitory concentration (IC50) of the samples was calculated by Prism GraphPad 6.0 (GraphPad Software, San Diego, CA). The data are presented as the mean ± SD for three independent experiments.
Click to Show/Hide
|
||||
| In Vitro Model | Lung adenocarcinoma | A549 cells | CVCL_0023 | ||
References
